Guide · Corporate, M&A and Private Equity
Venture Capital and Emerging Companies in Canada
Venture capital in Canada borrows its vocabulary from Silicon Valley but runs on Canadian corporate, securities and tax law. This page follows a start-up from incorporation through early instruments and priced rounds, covering founder arrangements, prospectus exemptions, employee equity and the tax planning that shapes founders' eventual exit.
Key takeaways
- Most start-ups incorporate federally under the CBCA or provincially in Ontario or British Columbia.
- Every issuance of shares or SAFEs needs a prospectus exemption under NI 45-106, often with a filing within 10 days.
- Canadian-controlled private corporations get favourable stock option tax timing and enhanced SR&ED credits.
- Founders can shelter gains with the CAD 1.25 million lifetime capital gains exemption if QSBC tests are met.
- A Delaware flip can help US fundraising but may cost CCPC status and Canadian tax benefits.
Venture capital in Canada in brief
Venture capital in Canada follows a familiar path: founders incorporate, issue themselves shares subject to vesting, raise early money from angels and accelerators on simple instruments, then close priced rounds of preferred shares led by venture funds. Canadian investors and founders use documents modelled on US forms, but those forms must be adapted to Canadian corporate statutes, provincial securities exemptions and Canadian tax rules. Getting the adaptations right early avoids expensive clean-up when a later investor or acquirer conducts due diligence.

Canadian start-ups also benefit from features that do not exist in the same form elsewhere. A Canadian-controlled private corporation (CCPC) can access enhanced refundable scientific research and experimental development (SR&ED) tax credits and favourable stock option taxation, and its founders may be able to shelter part of their gain on exit with the lifetime capital gains exemption. Preserving CCPC status, or deciding consciously to give it up, is a recurring theme in Canadian venture financing.
This page is part of our corporate, M&A and private equity practice overview. For later-stage investors and buyouts, see private equity in Canada.
Forming the company and founder arrangements
Where to incorporate
Most Canadian start-ups incorporate under the Canada Business Corporations Act (CBCA) or the corporate statute of their home province, usually Ontario or British Columbia. Federal incorporation provides name protection across Canada, but the CBCA requires that at least 25% of directors be resident Canadians, which can matter for founders living abroad or for boards that will include foreign investor nominees. Ontario repealed its resident-director requirement in 2021. CBCA corporations must also maintain a register of individuals with significant control and file it with Corporations Canada.
Founder shares and vesting
Founders usually subscribe for common shares at a nominal price at incorporation, then subject those shares to reverse vesting so that the company can buy back unvested shares at cost if a founder leaves. Investors expect vesting over several years with a one-year cliff, and often acceleration on a sale combined with termination. Canada has no equivalent of the US section 83(b) election because founders who buy shares at fair market value at the outset generally have no employment benefit to report; the key is to document the subscription price and timing carefully.
Intellectual property and restrictive covenants
Investors will check that all intellectual property created by founders, employees and contractors belongs to the company. Canadian copyright and patent law do not automatically vest every employee creation in the employer, and contractors keep ownership unless they assign it, so written assignments and waivers of moral rights are essential. In Ontario, the Employment Standards Act, 2000 bans most non-compete agreements entered into on or after 25 October 2021, with exceptions for executives and for sales of a business, so start-ups rely on confidentiality, non-solicitation and IP provisions instead. Our intellectual property pages explain ownership rules.
Early-stage instruments: SAFEs and convertible notes
Pre-seed and seed rounds in Canada commonly use simple agreements for future equity (SAFEs) or convertible notes. A SAFE gives the investor a right to receive shares in the next priced round at a discount or subject to a valuation cap, without interest or maturity. A convertible note is debt that converts on similar terms, with an interest rate and maturity date. Canadian versions of both instruments exist, adapted to Canadian corporate law and to the Interest Act and criminal interest rate rules for notes.
The Canadian tax treatment of SAFEs is less settled than that of shares or debt. A SAFE is not a share, so it generally does not start the holding period for the lifetime capital gains exemption and does not count as share ownership for CCPC control tests, but the analysis depends on the terms. Investors and founders should consider whether a SAFE held by a non-resident fund could be treated as a right to acquire shares that affects CCPC status, which is relevant to SR&ED credits and stock options.
Every SAFE or note is a security. The company must rely on a prospectus exemption to issue it, and conversion into shares may also need an exemption, as discussed below.
Priced rounds and venture capital documents
A priced round, typically a Series Seed or Series A, involves the issuance of a new class or series of preferred shares at a negotiated valuation. Canadian venture capital documents usually include a term sheet, a subscription agreement, amended articles setting out the share terms, a shareholders' agreement (often split into voting, investor rights and right-of-first-refusal agreements on the US model), and updated option plan documents. Canadian industry model documents exist and are widely used as a starting point.
| Term | Typical Canadian approach | Where it lives |
|---|---|---|
| Liquidation preference | 1x non-participating preference is the market norm in many rounds | Articles (share conditions) |
| Anti-dilution | Broad-based weighted average adjustment to conversion price | Articles |
| Protective provisions | Class vote of preferred holders on listed matters | Articles and shareholders' agreement |
| Board composition | Seats for founders, investors and sometimes an independent; resident-Canadian rule for CBCA companies | Voting or unanimous shareholder agreement |
| Pre-emptive and ROFR rights | Pro rata rights for major investors; company and investor ROFR on transfers | Shareholders' agreement |
| Drag-along | Triggered by board and specified majority of preferred and common | Shareholders' agreement |
Canadian corporate statutes give each class of shares certain rights to vote separately on changes that affect them, regardless of the share terms. Under the CBCA, holders of a class or series can vote separately on amendments that would, for example, change their rights or create a new class with superior rights. Venture investors rely on these statutory class votes alongside contractual protective provisions, and founders should understand that common shareholders also hold them.
Where a shareholders' agreement restricts the powers of the directors, it may be a unanimous shareholder agreement, which transfers directors' duties and liabilities to the shareholders who exercise those powers. Investors usually prefer to avoid that result and draft their consent rights accordingly.
Securities law exemptions for start-ups
Every issuance of shares, options, SAFEs or notes is a distribution of securities under provincial securities law and requires either a prospectus or an exemption. The main exemptions for venture capital financings are in National Instrument 45-106 Prospectus Exemptions:
- Accredited investor (s. 2.3). Individuals with financial assets over CAD 1 million net of related liabilities, net income over CAD 200,000 (CAD 300,000 with a spouse) in each of the last two years, or net assets of at least CAD 5 million, and entities with net assets of at least CAD 5 million, among other categories.
- Private issuer (s. 2.4). For companies with transfer restrictions and no more than 50 beneficial holders, excluding employees and former employees, selling to listed categories such as directors, close friends and accredited investors.
- Family, friends and business associates (s. 2.5). Available across Canada, with additional conditions in Ontario, including a signed risk acknowledgement.
- Employees, executive officers, directors and consultants (s. 2.24). For option plans and other compensation grants where participation is voluntary.
Reports of exempt distribution must be filed within 10 days after a distribution made under several of these exemptions, including the accredited investor and family, friends and business associates exemptions, in each jurisdiction where purchasers are located, with fees. The private issuer exemption does not require a report in most cases. Securities issued under exemptions are subject to resale restrictions, which for a non-reporting issuer mean they generally cannot be resold except under another exemption. See prospectus-exempt financings for detail.
Keep a running record of every issuance: date, purchaser, province, exemption relied on, and whether a report was filed. Missed filings are among the most common findings in venture capital due diligence, and correcting them before a Series A or an acquisition is far easier than explaining them during one.
Employee equity and tax planning
Stock options
Under s. 7 of the Income Tax Act (ITA), an employee who acquires shares under an option has an employment benefit equal to the difference between the share value at exercise and the exercise price. For options granted by a CCPC to arm's-length employees, taxation is deferred until the shares are sold. Employees may also claim a deduction of one-half of the benefit if conditions are met, including that the exercise price was not less than fair market value at grant.
For non-CCPC employers, the benefit is taxed at exercise and an annual limit applies to the deduction for some large employers. Option plans should be designed with these rules in mind.
Lifetime capital gains exemption
Founders who sell shares of a qualified small business corporation may shelter up to CAD 1.25 million of capital gains. Broadly, the shares must be shares of a small business corporation at the time of sale, must not have been owned by an unrelated person in the previous 24 months, and throughout that period more than 50% of the corporation's assets by value must have been used principally in an active business carried on primarily in Canada; at the time of sale substantially all assets must meet that test.
Large cash balances after a financing can jeopardize the asset test, so many founders hold shares through a family trust or holding company and purify assets before an exit. Budget 2026 proposes a further exemption for qualifying CCPC shares, which is a proposal until enacted.
SR&ED credits
CCPCs can earn enhanced, refundable SR&ED investment tax credits on an expenditure limit of CAD 6 million, phased out as taxable capital rises from CAD 15 million to CAD 75 million under s. 127(10.2) ITA. Losing CCPC status, for example because a non-resident or public company acquires control in fact, reduces those credits. See our tax pages for detail.
Cross-border rounds, governance and exits
The Delaware flip
Some Canadian start-ups raising from US investors reorganize so that a Delaware corporation becomes the parent of the Canadian operating company, a transaction known as a "flip". US investors are familiar with Delaware law and US exits can be simpler. The flip has costs: the Canadian company usually ceases to be a CCPC, losing enhanced SR&ED credits and favourable option treatment, and founders exchanging Canadian shares for US shares may realize a taxable gain unless exchangeable share structures are used. Intellectual property transfers out of Canada can also trigger tax.
Many Canadian rounds now close with US investors without a flip, using Canadian documents adapted to US expectations. The decision should be driven by where the business will raise its later rounds, where it expects to exit, and the value of the Canadian tax benefits it would give up. Foreign investment rules rarely bite at seed stage, but the national security provisions of the Investment Canada Act can apply to any investment by a non-Canadian in sensitive technology areas, regardless of size or control.
Governance of venture-backed companies
Once a company has taken venture capital, its board changes character. Investor nominees owe the same duties to the corporation as founder directors, and must act in its best interests rather than in the interest of the fund that appointed them. Conflicts arise most often in down rounds, bridge financings led by existing investors, and sales where preferred shareholders receive their liquidation preference and common shareholders receive little. Canadian courts look at whether the process was fair and whether the reasonable expectations of affected shareholders were respected, and the oppression remedy is available to minority holders, including founders and employees holding common shares.
Good practice includes disclosing conflicts, having independent directors or a committee consider insider-led financings, offering existing holders a pro rata right to participate, and keeping careful minutes. Where a financing is urgent, a rights offering to all shareholders or a post-closing catch-up right can reduce the risk of later claims. Information rights promised to investors should be honoured consistently, because a failure to deliver agreed financial statements or budgets is a common source of friction and, occasionally, litigation.
Exits
Most venture-backed Canadian companies exit through acquisition rather than an initial public offering. Acquirers conduct due diligence on the capitalization table, IP ownership, securities filings, employee classification and privacy compliance, and expect founders and key employees to sign new employment terms and sometimes holdbacks or retention arrangements. Option plans should state clearly what happens to vested and unvested options on a sale, including whether the acquirer may assume, substitute or cash out options, to avoid disputes with employees. Where a sale is to a foreign buyer in a sensitive technology area, the Investment Canada Act national security process should be considered in the timetable.
How TRW & Co helps venture capital clients
TRW & Co advises founders, emerging companies, angel investors and venture capital funds on Canadian start-up and venture capital matters. We set up companies and founder arrangements, prepare and negotiate SAFEs, convertible notes and priced-round documents, design option plans, and keep securities filings and capitalization tables in order. We coordinate with tax advisers on CCPC status, SR&ED and founders' exit planning, and advise on cross-border structures, including whether a flip makes sense. We are an independent firm and work with Canadian-licensed counsel where required. Contact us to discuss your financing. This page is general information, not legal advice.
Frequently asked questions
Do Canadian start-ups need to file anything when they issue shares to investors?
Often, yes. Each issuance must rely on a prospectus exemption under NI 45-106. Distributions under the accredited investor and family, friends and business associates exemptions, among others, require a report of exempt distribution within 10 days in each province where purchasers are located. The private issuer exemption generally does not require a report.
Are SAFEs used in Canada?
Yes. Canadian SAFEs adapted to Canadian corporate law are common in pre-seed and seed rounds. They are securities, so an exemption is needed to issue them. Their tax treatment is less settled than that of shares, which matters for founders' lifetime capital gains exemption holding periods and for preserving CCPC status.
Why does CCPC status matter to a start-up?
A Canadian-controlled private corporation can earn enhanced refundable SR&ED credits on up to CAD 6 million of qualifying expenditures, subject to a phase-out based on taxable capital, and its employees can defer tax on option benefits until they sell the shares. Control by non-residents or public companies, including through a Delaware flip, can end CCPC status.
Can a start-up require employees to sign non-compete agreements?
In Ontario, non-compete agreements entered into on or after 25 October 2021 are generally prohibited under the Employment Standards Act, 2000, except for certain executives and on the sale of a business. Other provinces rely on common law, under which courts enforce non-competes only if reasonable. Start-ups usually rely on confidentiality, IP assignment and non-solicitation clauses.
Should a Canadian start-up flip to Delaware?
Only after weighing benefits against costs. A flip can ease US fundraising and exits, but it usually ends CCPC status, affecting SR&ED credits and option taxation, and may trigger tax for founders and on IP transfers unless carefully structured. Many Canadian companies now raise from US investors without flipping.
Sources
General information only, not legal advice. References to statutes, courts and authorities describe published law and practice at the date shown.